AP NEWS

GI Pathologists at Inform Diagnostics Publish Noteworthy Articles in Major Journals

May 14, 2018

IRVING, Texas--(BUSINESS WIRE)--May 14, 2018--GI pathologists at Inform Diagnostics, formerly Miraca Life Sciences, continue to publish noteworthy articles in respected peer-reviewed medical journals.

One recent article challenges current clinical assumptions about gastrointestinal polyps. Published in American Journal of Gastroenterology, “Lesions of All Types Exist in Colon Polyps of All Sizes” reports the stratification of advanced neoplasia by polyp size. The authors from Inform Diagnostics, gastrointestinal pathologists Kevin Turner, DO, and Robert M. Genta, MD, with their collaborator Amnon Sonnenberg, MD, MSc., reviewed histopathologic records of 550,811 polyps from 483,998 unique patients who underwent colonoscopy with polypectomy between January 2008 and December 2014. The article concludes that “…one quarter of all advanced histopathology existed in polyps of <10 mm.”

Another significant recent article provides further diagnostic criteria for eosinophilia by quantifying the normal eosinophil content in the duodenum. “Quantification of the duodenal eosinophil content in adults: a necessary step for an evidence-based diagnosis of duodenal eosinophilia” was published in Alimentary Pharmacology & Therapeutics by authors Genta, Turner, and Sonnenberg. Eosinophils were counted in specimens from 370 adults. Additionally, patient records were extracted from a database of 458,668 adult subjects. The article concludes that “…a cut-off count of 20 eos/hpf would be useful to separate patients with normal from those with elevated duodenal eosinophilic infiltrations.”

The above article follows up on previous research led by Dr. Genta that establish criteria for the eosinophil content of the colon ( , 2017 ) and for the eosinophil content of the stomach ( , 2011 ). Earlier, researchers at Inform Diagnostics published the landmark paper on EoE: “Eosinophilic Esophagitis: A Prevalent Disease in the United States That Affects All Age Groups,” ( , 2008 ).

These recent publications highlight the commitment to research and advancing science among the gastrointestinal pathology faculty at Inform Diagnostics. The organization’s high case volume has created a large database that affords significant research opportunities. Additional GI scientific publications by authors at Inform Diagnostics may be viewed online.

Overall, Inform Diagnostics pathologists have more than 2,500 career publications and typically publish more than 35 research papers and book chapters each year. Additionally, Inform Diagnostics pathologists are cited more than three times the average for academic clinical medicine.

About Inform Diagnostics

Headquartered in Irving, Texas, Inform Diagnostics is the largest independent anatomic pathology provider in the United States. The organization was founded in 1996 and previously known as Miraca Life Sciences since 2012. Inform Diagnostics’ premier medical laboratories focus on GI pathology, dermatopathology, hematopathology, urologic pathology, and breast pathology. Each Inform Diagnostics pathologist is a fellowship-trained subspecialist. Learn more online about Inform Diagnostics’ extraordinary quality and service.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180514005945/en/

CONTACT: Inform Diagnostics

Joy Jennings, 214-596-7055

Joy.Jennings@InformDx.com

KEYWORD: UNITED STATES NORTH AMERICA TEXAS

INDUSTRY KEYWORD: HEALTH OTHER HEALTH RESEARCH SCIENCE

SOURCE: Inform Diagnostics

Copyright Business Wire 2018.

PUB: 05/14/2018 11:15 AM/DISC: 05/14/2018 11:15 AM

http://www.businesswire.com/news/home/20180514005945/en

AP RADIO
Update hourly